FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Börse Stuttgart 03:56:50 2024-06-19 pm EDT | ||
| 9.77 EUR | -2.40% |
|
| Current month | -18.72% | ||
| 1 month | -28.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 9.77 | -2.40% |
| 24-06-18 | 10.01 | +0.10% |
| 24-06-17 | 10 | -4.21% |
| 24-06-14 | 10.44 | -1.79% |
| 24-06-13 | 10.63 | -12.22% |
Delayed Quote Börse Stuttgart
Last update June 19, 2024 at 03:56 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG3DH1 |
| ISIN | DE000MG3DH10 |
| Date issued | 2024-04-30 |
| Strike | 114.4 $ |
| Maturity | Unlimited |
| Parity | 2.14 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.83 € |
|---|---|
| Lowest since issue | 9.77 € |
| Spread | 0.32 € |
| Spread % | 3.17% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.3
USD
Average target price
147
USD
Spread / Average Target
+7.06%
- Stock Market
- Certificates
- Certificat
